Last reviewed: June 7, 2026
Last updated: June 7, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Compounded semaglutide activates GLP-1 receptors in your brain within hours of injection, but the timeline for noticing effects varies by individual metabolism and starting dose. Understanding when to expect results helps you stay committed to treatment and recognize whether your current dose is working effectively for your goals.
First Week: Initial Appetite Suppression Begins
During your first 3–7 days on compounded semaglutide injection, your body begins responding to the medication's signal to your appetite centers. Many patients report a sudden shift in food interest—foods they previously craved no longer seem appealing, and portion sizes feel naturally smaller. This rapid response occurs because semaglutide binds to GLP-1 receptors in the hypothalamus, a brain region that regulates hunger and fullness signals.
Not every patient experiences appetite changes in week one; individual timing depends on your unique peptide-pathway genetics, liver function, and baseline metabolic state. Some people feel noticeable shifts by day 3, while others take 10–14 days to register clear differences. Keeping a simple food and hunger log during this window helps you recognize subtle changes you might otherwise miss.
Your compounded semaglutide dose begins at a conservative level to minimize nausea and other gastrointestinal side effects, so week-one effects tend to be modest. This low starting point is intentional—it allows your body to acclimate while you assess tolerance before dose increases.
Weeks 2–4: Stabilized Appetite Control and Early Dietary Changes
By the end of week two, most patients experience consistent appetite suppression and reduced food cravings throughout the day. Your meals become smaller naturally, and you may skip snacks you previously ate on autopilot. This period is critical because your body is adapting to the medication while you're building new eating patterns that don't require constant willpower.
During weeks 2–4, gastrointestinal side effects (nausea, mild constipation, or changes in digestion) often emerge as compounded semaglutide concentrations stabilize in your system. These effects typically peak around week two and gradually improve as your gut adapts; they rarely become intolerable. Staying hydrated, eating slowly, and choosing protein-rich foods help minimize discomfort.
Weight loss during this phase is usually modest—typically 2–5 pounds—because the primary mechanism is appetite reduction rather than calorie burning. This early weight loss reflects reduced food intake and initial fluid shifts, not yet the sustained fat loss that accelerates in weeks 4–8.
Weeks 4–8: Measurable Weight Loss and Medication Efficacy Assessment
By week four, most patients see measurable weight loss on the scale, with many reporting 3–7 pounds down from baseline. This timeframe marks when compounded semaglutide's full appetite-suppressing effect is clear, and your reduced calorie intake has shifted your body's energy balance toward fat loss. Energy levels often improve as well, particularly if weight-related fatigue was limiting your activity.
Your prescribing clinician typically evaluates your response at the 4-week mark to decide whether your current dose is sufficient or whether a gradual increase is appropriate. This assessment considers your hunger levels, side effects, weight loss rate, and your personal goals. PlexusDx's clinic partners can order a Precision Peptide Genetic Test after your first month to map your unique peptide-pathway variants (including GLP1R rs6923761 and GIPR rs1800437) and optimize your long-term dosing strategy.
By week 8, cumulative weight loss typically ranges from 5–12 pounds depending on your starting point, metabolism, and adherence. This is the period when you can most clearly assess whether your current medication choice and dose level align with your expectations, or whether your doctor should consider adjustments.
Beyond 8 Weeks: Sustained Effects and Long-Term Optimization
Compounded semaglutide's effects continue to strengthen as your body maintains lower appetite and improved satiety signals. Beyond week 8, weight loss typically continues at a steadier rate (averaging 1–2 pounds per week for many patients) because you've established stable lower-calorie eating patterns supported by the medication. Tolerance to gastrointestinal side effects usually improves significantly by this point, allowing most patients to feel well.
Long-term efficacy depends on maintaining your dose and continuing consistent injections; skipping doses or reducing frequency typically leads to appetite return within 3–5 days. Some patients benefit from gradual dose increases over 12–16 weeks to reach their optimal response level, following a titration schedule your prescriber sets. PlexusDx's compounded semaglutide injections start at $149 per month flat (your dose may need to go up, your price won't), making sustained treatment accessible without per-dose cost increases.
After 3–6 months of consistent use, most patients reach a plateau where weight loss slows because they've approached a new stable point. At this stage, the focus shifts to maintaining your new weight through continued medication use and the eating habits you've developed. Discussing your plateau with your clinician can inform whether your current dose remains optimal or whether adding complementary strategies (like increased activity or genetic-guided protocol adjustments) could restart progress.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
When should I expect to lose weight on compounded semaglutide?
Most patients notice decreased appetite within 3–7 days, but measurable weight loss typically begins between weeks 4–6 as cumulative calorie reduction takes effect. Starting dose and individual metabolism significantly influence this timeline; some people see scale movement by week 2, while others take 8 weeks to reach their first meaningful loss.
Why does semaglutide take weeks to show full effects?
Compounded semaglutide requires time to reach steady-state levels in your bloodstream, build receptor sensitivity in your brain's appetite centers, and allow your body to adapt to signals of fullness. Your prescriber typically starts at a low dose to assess safety and tolerability, meaning the full weight-loss effect emerges only after gradual dose increases over several weeks.
How much does PlexusDx compounded semaglutide cost, and does price change with dose?
PlexusDx compounded semaglutide injection starts at $149 per month across all dose levels—your dose may need to go up, but your price won't increase. HSA and FSA accounts are accepted, and PlexusDx serves all 50 states without requiring insurance or membership fees.
What if I don't feel effects after 4 weeks?
If appetite suppression is minimal or weight loss is absent after 4 weeks, discuss with your clinician whether your current dose is too low or whether you may respond better to a different GLP-1 medication like compounded tirzepatide. A Precision Peptide Genetic Test (available through PlexusDx for $99 after your first month) can reveal whether your GLP1R or GIPR genetic variants predict stronger response to tirzepatide or dual-compound therapy.
How does the Precision Peptide Genetic Test help predict my timeline?
PlexusDx's genetic test maps 14 peptide pathways and analyzes variants like GLP1R rs6923761, GIPR rs1800437, and FTO rs9939609 to reveal how your body naturally processes appetite and satiety signals. These insights guide whether standard semaglutide dosing will suit you or whether you may achieve faster results with tirzepatide or a personalized protocol adjustment.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What Is GLP-1 Good For? Exploring the Benefits and Uses of GLP-1 Agonists
Does Ozempic Help with Chronic Kidney Disease?